@article{Patil_2017, title={Efficacy and safety of blonanserin versus other antipsychotics: a review}, volume={2}, url={https://www.ijbcp.com/index.php/ijbcp/article/view/1350}, abstractNote={<p class="Abstract"><span lang="EN-IN">Although many atypical antipsychotics are available, there is a need of an atypical antipsychotic effective in all symptom domains of schizophrenia and well tolerated especially for side effects like extrapyramidal side effects, weight gain and blood prolactin elevation. Blonanserin is an atypical antipsychotic which blocks dopamine D2 and serotonin 5HT2A receptors. Its efficacy and safety has been studied in patients with schizophrenia and delirium. Blonanserin is found to be effective and well tolerated in both conditions. This article has reviewed efficacy and tolerability of blonanserin in these two psychiatry diseases.</span></p>}, number={6}, journal={International Journal of Basic & Clinical Pharmacology}, author={Patil, Anant D.}, year={2017}, month={Feb.}, pages={689–692} }